<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191022045187N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-12-27</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Tecar therapy on haematoma caused by hamstring muscle strain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of TENS current, Ultrasound and exercise with/without Tecar therapy on muscle haematoma, pain, pain pressure threshold and quality of life in Hamstring muscle strain injury</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-04-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43228</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple Randomization: Patients will be assigned a number according to the order of selection and will be divided into two treatment  groups by sortition. The first pulled out number would be assigned to the treatment group 1 and the subsequent numbers would be assigned treatment group 2, respectively.
Stratified randomization is based on gender and Body Mass Index (BMI), Blinding description: Only the Participants of the Study will be blinded. Patients would be assigned in two groups randomly. Difference of two groups is in intensity of  Tecar therapy(High frequency electromagnetic currents),  as in control group , Sham therapy (with zero intensity) would be applied and intensity of device in treatment group would be 20-30 percent. Patients will not be aware of intensity of Tecar device.</study_design>
      <phase>3</phase>
      <hc_freetext>Muscle Strain Injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in this group receive  Capacitive Tecar therapy ( High frequency electromagnetic currents), with intensity of 20-30 percent for 15 minutes in injury site of hamstring muscle ( Posterior area of thigh), then they are treated with 25 minutes of TENS ( AN analgesic electric currents  with frequency of 120 Hz) , after that patients receive 3-5 minutes of Pulsed Ultrasound therapy with duty cycle of 50-80 percent . After 5 treatment sessions, Isometric and stretching hamstring muscle exercises will be added to the treatment program ( treatment program includes 10 sessions in which 4 sessions would be in first week and 6 sessions in second and third week too). Intervention 2: Control group:  Patients in this group are treated with 25 minutes of TENS ( AN analgesic electric currents  with frequency of 120 Hz) , after that patients receive 3-5 minutes of Pulsed Ultrasound therapy with duty cycle of 50-80 percent. Capacitive Tecar therapy ( High frequency electromagnetic currents) in this group will be used as Sham therapy (with zero intensity) for 15 minutes in injury site of hamstring muscle ( Posterior area of thigh). After 5 treatment sessions, Isometric and stretching hamstring muscle exercises will be added to the treatment program ( treatment program includes 10 sessions in which 4 sessions would be in first week and 6 sessions in second and third week too).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Ali Adabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.4, Honarmand alley , Shahid beheshti Ave, Varamin Town , Tehran</address>
        <city>Varamin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3371843433</zip>
        <telephone>+98 21 3624 7842</telephone>
        <email>aliadabi_msc@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Khosro Khademi-Kalantari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation of Shahid Beheshti University of Medical Science, Damavand Ave, Emam Hossein Sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7756 1721</telephone>
        <email>k_khademi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18-40
Structural hamstring muscle strain injuries ( indirect muscle injuries)
Existence of muscle haematoma which is confirmed by imaging test
Patients with pain intensity of more than 3, in Visual Analog Scale
Absence of history of surgery or metal implantation in lower limb, especially in posterior area of hip and thigh
Not using Analgesic and Anticoagulant drugs</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy
Existence of tumor or malignant tissue
Having electronic implanted device such as pace maker
Open infected wounds
Treated with radiotherapy in last 6 month
Cardiovascular disorders
Tuberclosis
Unreliable patients</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S76.311A</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Strain of muscle, fascia and tendon of the posterior muscle group at thigh level</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in this group receive  Capacitive Tecar therapy ( High frequency electromagnetic currents), with intensity of 20-30 percent for 15 minutes in injury site of hamstring muscle ( Posterior area of thigh), then they are treated with 25 minutes of TENS ( AN analgesic electric currents  with frequency of 120 Hz) , after that patients receive 3-5 minutes of Pulsed Ultrasound therapy with duty cycle of 50-80 percent . After 5 treatment sessions, Isometric and stretching hamstring muscle exercises will be added to the treatment program ( treatment program includes 10 sessions in which 4 sessions would be in first week and 6 sessions in second and third week too).</i_keyword>
      <i_keyword>Control group:  Patients in this group are treated with 25 minutes of TENS ( AN analgesic electric currents  with frequency of 120 Hz) , after that patients receive 3-5 minutes of Pulsed Ultrasound therapy with duty cycle of 50-80 percent. Capacitive Tecar therapy ( High frequency electromagnetic currents) in this group will be used as Sham therapy (with zero intensity) for 15 minutes in injury site of hamstring muscle ( Posterior area of thigh). After 5 treatment sessions, Isometric and stretching hamstring muscle exercises will be added to the treatment program ( treatment program includes 10 sessions in which 4 sessions would be in first week and 6 sessions in second and third week too).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Area size of muscle haematoma. Timepoint: Before intervention, After 10 treatment sessions, After 1 and 2 month follow up. Method of measurement: Ultrasonography imaging.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain intensity. Timepoint: Before intervention, After 10 treatment sessions, After 1 and 2 month follow up. Method of measurement: Based on Visual Analog Scale.</sec_outcome>
      <sec_outcome>Pain Pressure Threshold. Timepoint: Before intervention, After 10 treatment sessions, After 1 and 2 month follow up. Method of measurement: By using Algometer device.</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: Before intervention, After 10 treatment sessions, After 1 and 2 month follow up. Method of measurement: Using SF-36 questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-01-15</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Science</contact_name>
        <contact_address>3rd Floor, Medical Faculty, Next to the Taleghani hospital, Evin, Shahid Chamran highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
